ES2121809T3 - N-(3-(2-(1h-imidazol-1-il)etoxi)fenil)-4-(2-tienil)-2-pirimidinamina y sales farmacologicamente aceptables. - Google Patents

N-(3-(2-(1h-imidazol-1-il)etoxi)fenil)-4-(2-tienil)-2-pirimidinamina y sales farmacologicamente aceptables.

Info

Publication number
ES2121809T3
ES2121809T3 ES92119890T ES92119890T ES2121809T3 ES 2121809 T3 ES2121809 T3 ES 2121809T3 ES 92119890 T ES92119890 T ES 92119890T ES 92119890 T ES92119890 T ES 92119890T ES 2121809 T3 ES2121809 T3 ES 2121809T3
Authority
ES
Spain
Prior art keywords
imidazol
acceptable salts
pharmacologically acceptable
pirimidinamine
tienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92119890T
Other languages
English (en)
Inventor
Rolf Paul
Robert Gerard Kelly
Lawrence W Torley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2121809T3 publication Critical patent/ES2121809T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

N-(3-[2-(1H-IMIDAZOL-1-IL)ETOXI)FENIL]-4-(2-TIENIL)-2-PIRIMIDINAMINA Y LAS SALES FARMACOLOGICAMENTE ACEPTABLES, UTILES COMO AGENTES ANTIASMA Y PARA EL TRATAMIENTO DE ENFERMEDADES ALERGICAS Y QUE PRESENTAN UNAS CARACTERISTICAS DE BIODISPONIBILIDAD MEJORADAS.
ES92119890T 1991-12-31 1992-11-23 N-(3-(2-(1h-imidazol-1-il)etoxi)fenil)-4-(2-tienil)-2-pirimidinamina y sales farmacologicamente aceptables. Expired - Lifetime ES2121809T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/816,335 US5162328A (en) 1991-12-31 1991-12-31 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Publications (1)

Publication Number Publication Date
ES2121809T3 true ES2121809T3 (es) 1998-12-16

Family

ID=25220310

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92119890T Expired - Lifetime ES2121809T3 (es) 1991-12-31 1992-11-23 N-(3-(2-(1h-imidazol-1-il)etoxi)fenil)-4-(2-tienil)-2-pirimidinamina y sales farmacologicamente aceptables.

Country Status (16)

Country Link
US (1) US5162328A (es)
EP (1) EP0549880B1 (es)
JP (1) JPH05271227A (es)
KR (1) KR930012761A (es)
AT (1) ATE171178T1 (es)
AU (1) AU651539B2 (es)
CA (1) CA2086357A1 (es)
DE (1) DE69227015T2 (es)
DK (1) DK0549880T3 (es)
ES (1) ES2121809T3 (es)
FI (1) FI925951A (es)
HU (1) HUT66943A (es)
NO (1) NO301476B1 (es)
NZ (1) NZ245513A (es)
SG (1) SG47556A1 (es)
ZA (1) ZA9210120B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007053776A1 (en) * 2005-11-03 2007-05-10 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751742T3 (de) * 1986-01-13 2002-11-21 American Cyanamid Co., Wayne 4,5,6-Substituierte 2-Pyrimidinamine
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines

Also Published As

Publication number Publication date
CA2086357A1 (en) 1993-07-01
FI925951A (fi) 1993-07-01
NO924760L (no) 1993-07-01
ZA9210120B (en) 1994-04-12
US5162328A (en) 1992-11-10
EP0549880A1 (en) 1993-07-07
AU651539B2 (en) 1994-07-21
EP0549880B1 (en) 1998-09-16
DE69227015D1 (de) 1998-10-22
DK0549880T3 (da) 1999-06-14
SG47556A1 (en) 1998-04-17
NO301476B1 (no) 1997-11-03
HUT66943A (en) 1995-01-30
HU9204172D0 (en) 1993-04-28
AU3046292A (en) 1993-07-08
FI925951A0 (fi) 1992-12-30
DE69227015T2 (de) 1999-03-25
ATE171178T1 (de) 1998-10-15
NO924760D0 (no) 1992-12-09
KR930012761A (ko) 1993-07-21
JPH05271227A (ja) 1993-10-19
NZ245513A (en) 1994-07-26

Similar Documents

Publication Publication Date Title
NO933093L (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on hydroklorid
UY26480A1 (es) Inhibidores de n - (5 - ( 5 - alquil - 2 - oxazolil) metil ) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina
ATE228119T1 (de) Heterocyclische carboxamide
KR920021522A (ko) 피페라진 유도체
BR0114870A (pt) Tratamento de tumores estromais gastrointestinais
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
NO20000227D0 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse
TR199802241T2 (es)
NO964950L (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl|-aminometyl}-kroman
CY1111191T1 (el) Θεραπευτικος παραγοντας για την διαταραχη του κερατο-επιπεφυκοτα
DE60110262D1 (de) Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren
FI952481A0 (fi) Substituoituja 3-(aminoalkyyliamino)-1,2-bentsisoksatoleja ja niihin liittyviä yhdisteitä
UY26481A1 (es) Inhibidores de n - (5 - ( ( (5 - alquil - 2 - oxazolil) metil) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina.
DK0474580T3 (da) Anvendelse af 1-(3-dimethylamino)propyl)-1-phenylphthalener til behandling af cerebrovaskulære sygdomme
KR910011251A (ko) 항알레르기제 및 항히스타민제 함유 조성물
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
ES2121809T3 (es) N-(3-(2-(1h-imidazol-1-il)etoxi)fenil)-4-(2-tienil)-2-pirimidinamina y sales farmacologicamente aceptables.
NO964269L (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksogluco-pyranosider, deres fremstilling og anvendelse
BR0312242A (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil]-benzamida para o tratamento da fibrose pulmonar
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
FI972528A0 (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
NZ336585A (en) 2,6-dimethyl-4-(3-nitro-phenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylate derivatives substituted by N-[5-(1H-2-pyrrolyl)-5-oxopentyl] or [4-(2-thienoyl or 2,4,6-trimethoxybenzoyl)-butyl]-pyrrolid-3-ine or piperid-3-ine
UY24465A1 (es) Antagonistas oxadiazol y tiadiazol del receptor muscarinico
UY26732A1 (es) N-(5-(5-alquil-2-oxazolil)metil)tio)-2- tiazolil) carboxamidas inhibidoras de cinasa dependientes de la ciclina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549880

Country of ref document: ES